Most health insurance providers and Medicare cover Gentle Cure. Medicare Part A covers radiation therapy when you are receiving inpatient treatment in the hospital. Part B covers radiation therapy for ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...

This test predicts cancer recurrence ... This represents an expansion from the prior Medicare coverage of Guardant Reveal testing for CRC only in the early post-surgical setting.

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

Five cancer drugs − Revlimid, Pomalyst, Imbruvica, Jakafi, and Ibrance − cost Medicare enrollees $11,000 to nearly $15,000 per drug in 2023, according to a KFF analysis. What's more ...